Results 31 to 40 of about 11,949 (217)

Insights into the Antibacterial Properties of Complement Peptides C3a, C4a, and C5a across Vertebrates [PDF]

open access: bronzeThe Journal of Immunology, 2022
Abstract Complement peptides C3a, C4a, and C5a are important components of innate immunity in vertebrates. Although they diverged from a common ancestor, only C3a and C4a can act as antibacterial peptides in Homo sapiens, suggesting that C5a has evolved into a purely chemotactic molecule; however, the antibacterial properties of C3a, C4a,
Xu‐Jie Zhang   +5 more
openalex   +4 more sources

Increased activation product of complement 4 protein in plasma of individuals with schizophrenia

open access: yesTranslational Psychiatry, 2021
Structural variation in the complement 4 gene (C4) confers genetic risk for schizophrenia. The variation includes numbers of the increased C4A copy number, which predicts increased C4A mRNA expression.
Agnieszka Kalinowski   +14 more
doaj   +1 more source

Changes in complement activation products after anti-VEGF injection for choroidal neovascularization in age-related macular degeneration and pachychoroid disease

open access: yesScientific Reports, 2021
We evaluated changes in the complement system resulting from anti-vascular endothelial growth factor (VEGF) in eyes with age-related choroidal neovascularization (CNV) including neovascular age-related macular degeneration, pachychoroid neovasculopathy ...
Keiichiro Tanaka   +13 more
doaj   +1 more source

Heterogeneity in the structural basis of the human complement C4A null allele (C4A*Q0) as revealed by HindIII restriction fragment length polymorphism analysis [PDF]

open access: bronzeFEBS Letters, 1987
The highly polymorphic fourth component of human complement (C4) is usually encoded by two genes, C4A and C4B, adjacent to the 21‐hydroxylase (21‐OH) genes, 21‐OHA and 21‐OHB, and is also remarkable in the high frequency of the ‘null’ alleles, C4A*Q0 and C4B*Q0.
B. Uring‐Lambert   +5 more
openalex   +4 more sources

Multi-ancestry phenome-wide association of complement component 4 variation with psychiatric and brain phenotypes in youth

open access: yesGenome Biology, 2023
Background Increased expression of the complement component 4A (C4A) gene is associated with a greater lifetime risk of schizophrenia. In the brain, C4A is involved in synaptic pruning; yet, it remains unclear the extent to which upregulation of C4A ...
Leanna M. Hernandez   +11 more
doaj   +1 more source

Cerebrospinal fluid concentration of complement component 4A is increased in first episode schizophrenia

open access: yesNature Communications, 2022
Schizophrenia risk has been associated with the complement component 4 (C4) genes. Here the authors show that C4A is elevated in individuals with schizophrenia.
Jessica Gracias   +31 more
doaj   +1 more source

Complement Split Products C3a and C4a in Chronic Lyme Disease [PDF]

open access: yesScandinavian Journal of Immunology, 2008
AbstractComplement split products C3a and C4a are reportedly elevated in patients with acute Lyme disease. We have now examined these immunologic markers in patients with chronic Lyme disease compared to appropriate disease controls. The study population consisted of 29 healthy controls, 445 patients with chronic Lyme disease, 11 patients with systemic
R B, Stricker   +3 more
openaire   +2 more sources

Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis

open access: yesnpj Genomic Medicine, 2022
Copy number (CN) polymorphisms of complement C4 play distinct roles in many conditions, including immune-mediated diseases. We investigated the association of C4 CN with systemic sclerosis (SSc) risk.
Martin Kerick   +24 more
doaj   +1 more source

Mannan-binding lectin and complement C4A in Icelandic multicase families with systemic lupus erythematosus [PDF]

open access: greenAnnals of the Rheumatic Diseases, 2006
To determine whether low mannan-binding lectin (MBL) and C4A null alleles (C4AQ0) are associated with systemic lupus erythematosus (SLE) in multicase families with SLE.Low MBL level was determined by measuring serum levels and by genotyping for mutant structural (B/C/D, designated as 0) and promoter (LX) alleles (by real-time polymerase chain reaction).
Saedís Saevarsdóttir   +5 more
openalex   +3 more sources

Home - About - Disclaimer - Privacy